AdvanTIG-205
Completed
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
BeOne Study ID
ClinicalTrials.gov ID
EudraCT Number
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
Study Documents
Plain Language SummaryStudy Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No